From: Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis
Characteristic | Baseline, n = 15 |
---|---|
Age, mean (SD) | 64.8 (15.4) |
Caucasian, n (%) | 15 (100) |
Sex, n (%) | |
Male | 6 (40) |
Female | 9 (60) |
Obesity with BMI > 30 kg/m2, n (%) | 12 (80) |
Clinical manifestation of calciphylaxis | |
Proximal body lesions, n (%) | 11 (73.3) |
Only distal body lesions, n (%) | 4 (26.7) |
CKD stage 4 and 5, n (%) | 12 (80) |
CKD5D, n (%) | 10 (66.7) |
Hyperparathyroidism, n (%) | 13 (86.7) |
Type 2 Diabetes, n (%) | 7 (46.7) |
Liver disease, n (%) | 2 (13.3) |
Biopsy proven calciphylaxis, n (%) | 15 (100) |
One-year mortality, n (%) | 11 (73.3) |